Literature DB >> 18045319

New Japanese pediatric guidelines for the treatment and management of bronchial asthma.

Akihiro Morikawa1, Sankei Nishima.   

Abstract

There have been a number of guidelines for asthma treatment published throughout the world. However, childhood asthma guidelines must be developed in consideration of the background of the individual countries. The second version of the Japanese Pediatric Guideline for the Treatment and Management of Bronchial Asthma 2002 (JPGL 2002) was published by the Japanese Society of Pediatric Allergy and Clinical Immunology (JSPACI) in November 2002, and was popular among Japanese physicians. After the publication of the JPGL, the incidence of pediatric asthma deaths decreased in Japan. In JPGL 2005 the recommendations were re-edited based on Global Initiative for Asthma (GINA) and the JPGL 2002. In comparison to the GINA guidelines, the JPGL 2005 include a classification system of asthma severity, recommendations for long-term management organized by age, a special mention of infantile asthma, and an emphasis on prevention and early intervention.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18045319     DOI: 10.1111/j.1442-200X.2007.02462.x

Source DB:  PubMed          Journal:  Pediatr Int        ISSN: 1328-8067            Impact factor:   1.524


  8 in total

1.  Impact of aminophylline on the pharmacodynamics of propofol in beagle dogs.

Authors:  Soo-Han Lee; Hyun-Ji Kang; Seok-Joon Jin; Do-Yang Park; Yoon-Ji Choi; Byung-Moon Choi; Eun-Kyung Lee; Gyu-Jeong Noh
Journal:  J Pharmacokinet Pharmacodyn       Date:  2014-08-24       Impact factor: 2.745

2.  Theophylline potentiates lipopolysaccharide-induced NO production in cultured astrocytes.

Authors:  Mizue Ogawa; Katsura Takano; Kenji Kawabe; Mitsuaki Moriyama; Hideshi Ihara; Yoichi Nakamura
Journal:  Neurochem Res       Date:  2014-01       Impact factor: 3.996

3.  Effects of leukotriene receptor antagonists on peripheral eosinophil counts and serum IgE levels in children with food allergy.

Authors:  Yoko Yamakawa; Yoshikazu Ohtsuka; Kiyotaka Ohtani; Tohru Fujii; Satoru Nagata; Yuichiro Yamashiro; Toshiaki Shimizu
Journal:  Drugs R D       Date:  2010

4.  Budesonide inhalation suspension versus methylprednisolone for treatment of moderate bronchial asthma attacks.

Authors:  Noriyuki Yanagida; Morimitsu Tomikawa; Akinori Shukuya; Masamichi Iguchi; Motohiro Ebisawa
Journal:  World Allergy Organ J       Date:  2015-05-05       Impact factor: 4.084

5.  Association between traffic-related air pollution and asthma in preschool children in a national Japanese nested case-control study.

Authors:  Hideki Hasunuma; Tosiya Sato; Tsutomu Iwata; Yoichi Kohno; Hiroshi Nitta; Hiroshi Odajima; Toshimasa Ohara; Takashi Omori; Masaji Ono; Shin Yamazaki; Masayuki Shima
Journal:  BMJ Open       Date:  2016-02-25       Impact factor: 2.692

6.  Pranlukast reduces asthma exacerbations during autumn especially in 1- to 5-year-old boys.

Authors:  Yoshinori Morita; Eduardo Campos Alberto; Shuichi Suzuki; Yoshinori Sato; Akira Hoshioka; Hiroki Abe; Kimiyuki Saito; Toshikazu Tsubaki; Mana Haraki; Akiko Sawa; Yoshio Nakayama; Hiroyuki Kojima; Midori Shigeta; Fumiya Yamaide; Yoichi Kohno; Naoki Shimojo
Journal:  Asia Pac Allergy       Date:  2017-01-26

7.  Exhaled carbon monoxide levels in infants and toddlers with episodic asthma.

Authors:  Yoichiro Ohara; Takahiro Ohara; Koichi Hashimoto; Mitsuaki Hosoya
Journal:  Fukushima J Med Sci       Date:  2020-06-27

8.  New efficacy of LTRAs (montelukast sodium): it possibly prevents food-induced abdominal symptoms during oral immunotherapy.

Authors:  Masaya Takahashi; Shoichiro Taniuchi; Kazuhiko Soejima; Kyoko Sudo; Yasuko Hatano; Kazunari Kaneko
Journal:  Allergy Asthma Clin Immunol       Date:  2014-01-17       Impact factor: 3.406

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.